Scrophularia Atropatana Extract Reverses TP53 Gene Promoter Hypermethylation and Decreases Survivin Antiapoptotic Gene Expression in Breast Cancer Cells
Overview
Authors
Affiliations
Background: In many cases of breast cancer, the aberrant methylation of TP53 gene leads to uncontrolled cell proliferation and apoptosis inhibition. Moreover, expression of oncogenes which are under the control of P53 protein could be altered. Survivin as a conspicuous example of this category plays important roles in tumorigenesis, drug resistance and apoptosis inhibition. The present study was done to reveal the effects of Scrophularia atropatana extract on epigenetic situation of TP53 gene promoter and the expression levels of anti-apoptotic gene, survivin and its potential for production of cancer epi-drugs. Methods: Cytotoxic effect of dichloromethane extracts of Scrophularia plant on MCF-7 cell line was assessed in our previous study. Cell death ELISA (enzyme-linked immunosorbent assay) and TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) tests were used to investigate the occurrence of apoptosis in the treated cells. Methylation Specific PCR (MSP) was employed to assess the changes in methylation status of the TP53 gene promoter. Furthermore, quantitative real time PCR was utilized to evaluate the resulting changes in TP53 and survivin genes expression. Results: Cell death ELISA and TUNEL assays confirmed the occurrence of apoptosis. MSP test revealed a significant change in the methylation status of TP53 promoter. QRT-PCR showed an increased TP53 gene expression in the treated cells while a significant decrease in survivin mRNA was evident. Conclusions: According to the outcomes, dichloromethane extract of S. atropatana returned the TP53 gene promoter hypermethylation to normal state. This plant could be a promising source for production of epi-drugs due to its apoptotic effects and reversal of TP53 epigenetic alterations.
Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells.
Rasi F, Zarredar H, Amini M, Onsori H, Dadashzadeh K, Khanmohammadi M Asian Pac J Cancer Prev. 2023; 24(10):3389-3395.
PMID: 37898842 PMC: 10770681. DOI: 10.31557/APJCP.2023.24.10.3389.
Tang G, Cho M, Wang X Nucleic Acids Res. 2021; 50(D1):D1334-D1339.
PMID: 34718715 PMC: 8728272. DOI: 10.1093/nar/gkab970.
MethHC 2.0: information repository of DNA methylation and gene expression in human cancer.
Huang H, Li J, Tang Y, Huang Y, Chen Y, Xie Y Nucleic Acids Res. 2020; 49(D1):D1268-D1275.
PMID: 33270889 PMC: 7779066. DOI: 10.1093/nar/gkaa1104.
Evaluation of the Methylation of MIR129-2 Gene in Gastric Cancer.
Alizadeh N, Asadi M, Shanehbandi D, Zafari V, Shomali N, Asvadi T J Gastrointest Cancer. 2019; 51(1):267-270.
PMID: 31073863 DOI: 10.1007/s12029-019-00239-4.